• ELPUB_slider



Our (e)Books and (e)Journals

IOS Press serves the information needs of scientific and medical communities worldwide. See what's new and browse our books and journals to learn more.

  • kudos_static_310_x_62
  • Slider Journal Catalogue 2016
  • go-to-ejournals
  • Go to IOS Press Ebooks
  • Millpress and Delft University Press imprints IOS Press
  • Statement side banner
  • worldofstatisticsbanner



Deep Brain Stimulation continues to show promise for patients with mild Alzheimer’s disease

July 21, 2016 - New findings published today by a team of researchers led by Dr. Andres Lozano at the Krembil Neuroscience Centre (KNC) of Toronto Western Hospital (TWH) have provided further insight into the effects of Deep Brain Stimulation (DBS) in the treatment of Alzheimer’s disease.

July 21, 2016

Special Issue of NeuroRehabilitation Investigates the Effectiveness of Treatment for Individuals with Brain Injury or Stroke

July 20, 2016 - In the current issue of NeuroRehabilitation leading researchers explore the effectiveness of several neurorehabilitation treatments for individuals with brain injury or stroke. A number of published articles have covered the issue of efficacy of neurorehabilitation, but only a few have discussed the issue of effectiveness.

July 20, 2016

Driving ability of people with cognitive impairment difficult to assess: research review

July 19, 2016 - No single assessment tool is able to consistently determine driving ability in people with Alzheimer’s disease and mild cognitive impairment, a St. Michael’s Hospital research review has found.

July 19, 2016

Mark W. Bondi, PhD, Recipient of 2016 Alzheimer Award

July 15, 2016 - The Journal of Alzheimer’s Disease (JAD) is pleased to announce that Mark W. Bondi, PhD, ABPP/CN, Professor of Psychiatry at UC San Diego and Director of the Neuropsychological Assessment Unit at the VA San Diego Healthcare System, has been chosen as the recipient of the 2016 Alzheimer Award presented by the journal in recognition of his outstanding work on the development of a novel and promising method of staging preclinical Alzheimer’s disease (AD) based on number of abnormal biomarkers that is predictive of progression to mild cognitive impairment (MCI) and AD.

July 15, 2016